Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene

    Genetic Testing and Molecular Biomarkers, Vol. 20, Núm. 8, pp. 465-470

  2. A cannabinoid link between mitochondria and memory

    Nature, Vol. 539, Núm. 7630, pp. 555-559

  3. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575

  4. Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease

    Neuroscience, Vol. 329, pp. 284-293

  5. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

    Nanomedicine, Vol. 11, Núm. 10, pp. 1267-1285

  6. Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia

    Science Signaling, Vol. 9, Núm. 410

  7. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

  8. Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia

    Schizophrenia Research, Vol. 177, Núm. 1-3, pp. 88-97

  9. Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex

    Frontiers in Pharmacology, Vol. 7, Núm. NOV

  10. Buspirone requires the intact nigrostriatal pathway to reduce the activity of the subthalamic nucleus via 5-HT1A receptors

    Experimental Neurology, Vol. 277, pp. 35-45

  11. CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: A case-control study

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 66-73

  12. Chronic L-DOPA administration increases the firing rate but does not reverse enhanced slow frequency oscillatory activity and synchronization in substantia nigra pars reticulata neurons from 6-hydroxydopamine-lesioned rats

    Neurobiology of Disease, Vol. 89, pp. 88-100

  13. Cystine/glutamate antiporter blockage induces myelin degeneration

    GLIA, Vol. 64, Núm. 8, pp. 1381-1395

  14. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine

    Neuropharmacology, Vol. 101, pp. 76-86

  15. Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: A case report and analysis of cases reported in the European pharmacovigilance database

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 3, pp. 368-370

  16. Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study

    Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867

  17. Efficacy of pregabalin in the treatment of neuropathic pain: Systematic review

    Gaceta Medica de Bilbao, Vol. 113, Núm. 3, pp. 113-128

  18. Evaluación de la causalidad en las comunicaciones de reacciones adversas a medicamentos. Algoritmo del Sistema Español de Farmacovigilancia

    Medicina Clinica, Vol. 147, Núm. 10, pp. 461-464

  19. Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 41, Núm. 3, pp. E46-E55

  20. Fast and efficient neural conversion of human hematopoietic cells

    Current Protocols in Stem Cell Biology, Vol. 2016, pp. 1-20